Skip to content

Where to inject Ozempic, Zepbound, Mounjaro and Wegovy

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Where to inject Ozempic: under the skin of your abdomen, thigh or upper arm. Wegovy, Saxenda and Trulicity use the same three sites. Zepbound and Mounjaro are different. You inject them in the abdomen or thigh, and the back of the upper arm is used only when another person gives the injection. All six labels say to rotate sites.

Source: FDA label (DailyMed)

Key takeaways

  • Ozempic, Wegovy, Saxenda and Trulicity: abdomen, thigh or upper arm, under the skin.
  • Zepbound and Mounjaro: abdomen or thigh yourself. The back of the upper arm only if another person injects.
  • Rotating means a new spot each time. No label requires a new body region.
  • With Ozempic, Mounjaro or Trulicity plus insulin: separate injections, never mixed, and not side by side.
  • Using insulin with Zepbound, Wegovy or Saxenda? Ask your prescriber or pharmacist how to space the injections.

Every injectable GLP-1 label names the same three parts of the body: the abdomen, the thigh and the upper arm. Two things change from label to label. One is who may use the upper arm. The other is how the label words rotation. This page puts the six labels side by side. For the rest of your injection routine (timing, needles, pens versus vials), see the how to inject guide.

GLP-1 injection sites, drug by drug

Medicine Sites named on the label
Zepbound (tirzepatide) Abdomen, thigh, or the back of the upper arm when another person injects
Mounjaro (tirzepatide) Abdomen, thigh, or the back of the upper arm when another person injects
Wegovy injection (semaglutide) Abdomen, thigh or upper arm
Ozempic injection (semaglutide) Abdomen, thigh or upper arm
Saxenda (liraglutide) Abdomen, thigh or upper arm
Trulicity (dulaglutide) Abdomen, thigh or upper arm

All six are subcutaneous injections. That means the medicine goes into the tissue just under the skin. The Zepbound label spells out what that rules out: do not inject into a muscle or a vein. The Wegovy pen is labeled for subcutaneous use only.

The tablets (Wegovy tablets, Ozempic tablets, Rybelsus and Foundayo) are swallowed. They have no injection site at all.

Zepbound injection sites: where to inject Zepbound and Mounjaro

You can inject Zepbound or Mounjaro yourself in the abdomen or thigh. The back of the upper arm is for someone else to inject.

The two tirzepatide labels use nearly identical wording. Zepbound: “Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm.” Mounjaro: inject in the abdomen or thigh, “or have another person inject MOUNJARO in the back of the upper arm.”

So the label gives you two sites to inject yourself, the abdomen and the thigh. The back of the upper arm is a labeled site too, but the label hands it to a second person. Both labels then say to rotate injection sites with each dose.

The wording is about the medicine, not one device. The label doesn’t give a different list of sites for the single-dose pen, the KwikPen or the vial.

Where to inject Ozempic and Wegovy

You can use the abdomen, thigh or upper arm. Both semaglutide injection labels list those three, and neither says another person must give an upper arm injection.

The rotation wording differs a little between the two:

  • Ozempic: patients are told “to use a different injection site each week when injecting in the same body region.” You can use your abdomen every week, as long as the spot moves.
  • Wegovy: “Rotate injection sites with each dose.” The label adds that you can change the injection site, and the time of day, without a dosage modification (a change to your dose).

Where to inject Saxenda and Trulicity

Saxenda goes in the abdomen, thigh or upper arm, once daily. The label says no dosage adjustment is needed if you change the site or the timing. Because Saxenda is daily, you rotate seven times as often as with a weekly pen. The label says to rotate injection sites within the same region, and it gives the reason: to reduce the risk of cutaneous amyloidosis (protein deposits in the skin). Saxenda is the only label in our records that names that risk in its site instructions.

Trulicity goes in the abdomen, thigh or upper arm once weekly, rotating sites with each dose.

Can you inject in the same area as insulin?

On the three labels in our records that cover this, yes, but not right next to it. They agree. For Ozempic, Mounjaro and Trulicity:

  • give the GLP-1 and insulin as separate injections, and never mix them
  • the same body region is acceptable
  • the two injections should not be adjacent to each other

So if both go in your abdomen, they go in different spots, not side by side. If you use insulin with Zepbound, Wegovy or Saxenda, ask your prescriber or pharmacist how to space the injections.

What “rotate” means in plain terms

It means you don’t keep using the exact same spot. Read together, none of the six labels sets a distance between spots or a fixed pattern, and none says you must change body region each time. The Ozempic and Saxenda labels describe rotation within one region. The Zepbound, Mounjaro, Trulicity and Wegovy labels just say to rotate sites with each dose.

An easy way to keep track is to write down the site next to the date of each dose. If you already log doses to see when your next fill is due, the supply tracker gives you the dates to write against.

What the labels do not say

No label in our records ranks the abdomen, thigh and upper arm. How far from the navel to inject, and how far apart to space your sites, is shown in the diagrams in the Instructions for Use. For those questions, and for injecting through scars, bruises or tattoos, use the Instructions for Use in the carton and ask the pharmacist who fills your prescription. Reactions at the injection site, and how often each label reports them, are on the injection site reactions page.

  • A healthcare provider should show you how to inject before your first dose, according to the Lilly patient information. The main guide lists what each label says about training.
  • How you store a pen decides whether you can use it at all. See storage and travel.
  • Used pens and needles go into a sharps container. See sharps disposal.

Frequently asked questions

Can I inject Zepbound in my arm by myself?

Not according to the label. The Zepbound label names the abdomen and thigh for injection and says another person should inject in the back of the upper arm. The Mounjaro label is set up the same way: abdomen, thigh, or have another person inject in the back of the upper arm. If you want to use your arm, someone else gives that injection.

Where is the best place to inject Ozempic?

The Ozempic label doesn't rank the sites. It lists the abdomen, thigh or upper arm. It tells you to use a different injection site each week when you inject in the same body region. Which of those labeled sites you use comes down to comfort and your prescriber's advice.

Do I have to switch between stomach and thigh every week?

No. No label in our records requires you to change body region each time. The Zepbound, Mounjaro, Trulicity and Wegovy labels say to rotate injection sites with each dose. The Ozempic and Saxenda labels talk about a different site within the same region. Moving to a new spot meets both, and that spot can be in the same area.

Does changing injection site change how the dose works?

Two labels answer this. The Wegovy label says the time of day and the injection site can be changed without the need for a dosage modification (no change to your dose). The Saxenda label says no dosage adjustment is needed if you change the injection site or timing.

Sources (13)

  1. 1.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose.”
  2. 2.
    FDA label (DailyMed): Zepbound Medication Guide (in the prescribing information)
    “Do not inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).”
  3. 3.
    FDA label (DailyMed): Mounjaro prescribing information, section 2.2
    “Inject MOUNJARO subcutaneously in the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm. Rotate injection sites with each dose.”
  4. 4.
    FDA label (DailyMed): Mounjaro prescribing information, section 2.2
    “When using MOUNJARO with insulin, administer as separate injections and never mix. It is acceptable to inject MOUNJARO and insulin in the same body region, but the injections should not be adjacent to each other.”
  5. 5.
    FDA label (DailyMed): Trulicity prescribing information, section 2.4
    “Inject TRULICITY subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites with each dose.”
  6. 6.
    FDA label (DailyMed): Trulicity prescribing information, section 2.4
    “When using TRULICITY with insulin, administer as separate injections and never mix. It is acceptable to inject TRULICITY and insulin in the same body region, but the injections should not be adjacent to each other.”
  7. 7.
    FDA label (DailyMed): Wegovy prescribing information, section 2.1
    “Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be changed without the need for a dosage modification.”
  8. 8.
    FDA label (DailyMed): Wegovy prescribing information, section 2.1
    “Rotate injection sites with each dose.”
  9. 9.
    FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
    “Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
  10. 10.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm. Instruct patients to use a different injection site each week when injecting in the same body region.”
  11. 11.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “When using OZEMPIC with insulin, instruct patients to administer as separate injections and to never mix the products. It is acceptable to inject OZEMPIC and insulin in the same body region, but the injections should not be adjacent to each other.”
  12. 12.
    FDA label (DailyMed): Saxenda prescribing information, section 2.1
    “Inject SAXENDA subcutaneously in the abdomen, thigh, or upper arm. No dosage adjustment is needed if changing the injection site and/or timing.”
  13. 13.
    FDA label (DailyMed): Saxenda prescribing information, section 2.1
    “Rotate injection sites within the same region in order to reduce the risk of cutaneous amyloidosis”